Interleukin-15 as a Biomarker Candidate of Rheumatoid Arthritis Development
Open Access
- 20 May 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (5), 1555
- https://doi.org/10.3390/jcm9051555
Abstract
There is a need for definite diagnosis of rheumatoid arthritis (RA) at its earliest stages of development in order to introduce early and effective treatment. Here we assessed whether serum interleukin-15 (IL-15) can serve as a new biomarker of RA development in patients with undifferentiated arthritis (UA). Interleukin-15, IgM-rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (anti-CCP Abs) were measured in UA patients at inclusion. Six months later, the diagnosis was re-evaluated, and statistical analysis was performed. We found that at the UA stage, IL-15 was more prevalent in patients who progressed to RA than RF or anti-CCP Abs (83.3% vs. 61.1% and 66.7%, respectively). Interleukin-15 showed higher sensitivity (77.8%) than both autoantibodies and higher specificity (80.9%) than anti-CCP Abs in identification of UA patients who developed RA. The diagnostic utility of IL-15 was comparable to that of RF (AUC: 0.814 vs. 0.750, p > 0.05), but higher than that of anti-CCP Abs (AUC: 0.814 vs. 0.684, p = 0.04). The combined use of IL-15, RF and anti-CCP Abs yielded higher diagnostic accuracy for RA than autoantibodies determination only. Our results indicate that IL-15 can be used as a biomarker of RA development in patients with UA.This publication has 33 references indexed in Scilit:
- Interleukin 15 Levels in Serum May Predict a Severe Disease Course in Patients with Early ArthritisPLOS ONE, 2011
- The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age‐dependent mannerArthritis & Rheumatism, 2010
- Elevated number of recently activated T cells in bone marrow of patients with rheumatoid arthritis: a role for interleukin 15?Annals Of The Rheumatic Diseases, 2010
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeAnnals Of The Rheumatic Diseases, 2010
- Up‐regulation of cytokines and chemokines predates the onset of rheumatoid arthritisArthritis & Rheumatism, 2010
- Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort studyAnnals Of The Rheumatic Diseases, 2006
- Targeting interleukin‐15 in patients with rheumatoid arthritis: A proof‐of‐concept studyArthritis & Rheumatism, 2005
- Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritisRheumatology, 2004
- Influence of disease‐modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: Results from a large observational inception studyArthritis & Rheumatism, 2003
- DIFFERENTIATING PERSISTENT FROM SELF-LIMITING SYMMETRICAL SYNOVITIS IN AN EARLY ARTHRITIS CLINICRheumatology, 1993